Nutrition, Metabolism & Cardiovascular Diseases
Volume 20, Issue 6 , Pages 394-404 , July 2010

Epidemiology of cardiovascular disease in Asian women

  • D. Hu

      Affiliations

    • Department of Preventive Medicine, Shenzhen University School of Medicine, 3688 Nanhai Avenue, Shenzhen, Guangdong 518060, China
    • Corresponding Author InformationCorresponding author. Tel.: +86 755 86671909; fax: +86 755 86671906.
    • ,
  • D. Yu

      Affiliations

    • Division of Community Health Sciences, St George's University of London, Cranmer Terrace, London SW17 0RE, UK

Received 30 April 2009 ,Revised 5 February 2010 ,Accepted 18 February 2010.

References 

  1. Lloyd-Jones DM, Larson MG, Beiser A, Levy D. Lifetime risk of developing coronary heart disease. Lancet. 1999;353(9147):89–92
  2. Sanderson JE, Mayosi B, Yusuf S, Reddy S, Hu S, Chen Z, et al. Global burden of cardiovascular disease. Heart. 2007;93(10):1175
  3. Mosca L, Linfante AH, Benjamin EJ, Berra K, Hayes SN, Walsh BW, et al. National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation. 2005;111(4):499–510
  4. Mosca L, Grundy SM, Judelson D, King K, Limacher M, Oparil S, et al. AHA/ACC scientific statement: consensus panel statement. Guide to preventive cardiology for women. American Heart Association/American College of Cardiology. J Am Coll Cardiol. 1999;33(6):1751–1755
  5. He J, Gu D, Wu X, Reynolds K, Duan X, Yao C, et al. Major causes of death among men and women in China. N Engl J Med. 2005;353(11):1124–1134
  6. Gu D, Gupta A, Muntner P, Hu S, Duan X, Chen J, et al. Prevalence of cardiovascular disease risk factor clustering among the adult population of China: results from the international collaborative study of cardiovascular disease in Asia (InterAsia). Circulation. 2005;112(5):658–665
  7. Epping-Jordan JE, Galea G, Tukuitonga C, Beaglehole R. Preventing chronic diseases: taking stepwise action. Lancet. 2005;366(9497):1667–1671
  8. WHO Statistical Information System . Causes of death: mortality and health status. WHO data and statistics. Available at 2008;http://www.who.int/research/en/
  9. Wu Z, Yao C, Zhao D, Wu G, Wang W, Liu J, et al. Cardiovascular disease risk factor levels and their relations to CVD rates in China – results of Sino-MONICA project. Eur J Cardiovasc Prev Rehabil. 2004;11(4):275–283
  10. Yoshida M, Kita Y, Nakamura Y, Nozaki A, Okayama A, Sugihara H, et al. Incidence of acute myocardial infarction in Takashima, Shiga, Japan. Circ J. 2005;69(4):404–408
  11. Mak KH, Chia KS, Kark JD, Chua T, Tan C, Foong BH, et al. Ethnic differences in acute myocardial infarction in Singapore. Eur Heart J. 2003;24(2):151–160
  12. Chadha SL, Ramachandran K, Shekhawat S, Tandon R, Gopinath N. A 3-year follow-up study of coronary heart disease in Delhi. Bull World Health Organ. 1993;71(1):67–72
  13. Parikh NI, Gona P, Larson MG, Fox CS, Benjamin EJ, Murabito JM, et al. Long-term trends in myocardial infarction incidence and case fatality in the National Heart, Lung, and Blood Institute's Framingham Heart study. Circulation. 2009;119(9):1203–1210
  14. Lowel H, Meisinger C, Heier M, Hormann A. The population-based acute myocardial infarction (AMI) registry of the MONICA/KORA study region of Augsburg. Gesundheitswesen. 2005;67(Suppl. 1):S31–S37
  15. Zhao D, Liu J, Wang W, Zeng Z, Cheng J, Sun J, et al. Epidemiological transition of stroke in China: twenty-one-year observational study from the Sino-MONICA-Beijing project. Stroke. 2008;39(6):1668–1674
  16. Kim HC, Nam CM, Jee SH, Suh I. Comparison of blood pressure-associated risk of intracerebral hemorrhage and subarachnoid hemorrhage: Korea Medical Insurance Corporation study. Hypertension. 2005;46(2):393–397
  17. Kimura Y, Takishita S, Muratani H, Kinjo K, Shinzato Y, Muratani A, et al. Demographic study of first-ever stroke and acute myocardial infarction in Okinawa, Japan. Intern Med. 1998;37(9):736–745
  18. Dalal PM, Malik S, Bhattacharjee M, Trivedi ND, Vairale J, Bhat P, et al. Population-based stroke survey in Mumbai, India: incidence and 28-day case fatality. Neuroepidemiology. 2008;31(4):254–261
  19. Shahar E, Mcgovern PG, Pankow JS, Doliszny KM, Smith MA, Blackburn H, et al. Stroke rates during the 1980s. The Minnesota stroke survey. Stroke. 1997;28(2):275–279
  20. Kolominsky-Rabas PL, Sarti C, Heuschmann PU, Graf C, Siemonsen S, Neundoerfer B, et al. A prospective community-based study of stroke in Germany – the Erlangen Stroke Project (ESPRO): incidence and case fatality at 1, 3, and 12 months. Stroke. 1998;29(12):2501–2506
  21. Rothwell PM, Coull AJ, Giles MF, Howard SC, Silver LE, Bull LM, et al. Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet. 2004;363(9425):1925–1933
  22. Sun JY, Zhao D, Wang W, Liu J, Cheng J, Jia YN. [The changing case-fatality of acute stroke in Beijing during 1984 to 2000]. Zhonghua Nei Ke Za Zhi. 2007;46(5):362–365
  23. Zhao DWZ, Wang W, Yao L, Zhou M. The trend of incidence rate of acute coronary events from 1984 to 1997 in Beijing area: Sino-MONICA project. Zhonghua Xin Xue Guan Bing Za Zhi. 2000;28(1):14–17
  24. Levi F, Lucchini F, Negri E, La Vecchia C. Trends in mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world. Heart. 2002;88(2):119–124
  25. Prevalence of hypertension in German. Available at http://www.who.int/infobase/reportviewer.aspx?rptcode=all&uncode=276&dm=18&surveycode=102311a1[accessed 2008]
  26. CHD 2005: blood pressure. Chapter 9 of the BHF coronary heart disease statistics. Published June 2005. Available at http://www.heartstats.org/datapage.asp?id=5340[accessed 2007]
  27. Cutler JA, Sorlie PD, Wolz M, Thom T, Fields LE, Roccella EJ. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988–1994 and 1999–2004. Hypertension. 2008;52(5):818–827
  28. Gupta R, Kaul V, Bhagat N, Agrawal M, Gupta VP, Misra A, et al. Trends in prevalence of coronary risk factors in an urban Indian population: Jaipur Heart Watch-4. Indian Heart J. 2007;59(4):346–353
  29. Jo I, Ahn Y, Lee J, Shin KR, Lee HK, Shin C. Prevalence, awareness, treatment, control and risk factors of hypertension in Korea: the Ansan study. J Hypertens. 2001;19(9):1523–1532
  30. Wu Y, Huxley R, Li L, Anna V, Xie G, Yao C, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from the China national nutrition and health survey 2002. Circulation. 2008;118(25):2679–2686
  31. Tsutsumi A, Kayaba K, Tsutsumi K, Igarashi M. Association between job strain and prevalence of hypertension: a cross sectional analysis in a Japanese working population with a wide range of occupations: the Jichi Medical School cohort study. Occup Environ Med. 2001;58(6):367–373
  32. Mishra V, Arnold F, Semenov G, Hong R, Mukuria A. Epidemiology of obesity and hypertension and related risk factors in Uzbekistan. Eur J Clin Nutr. 2006;60(12):1355–1366
  33. Bhalla V, Fong CW, Chew SK, Satku K. Changes in the levels of major cardiovascular risk factors in the multi-ethnic population in Singapore after 12 years of a national non-communicable disease intervention programme. Singapore Med J. 2006;47(10):841–850
  34. International Health Policy Program – Thailand. Innovative financing of health promotion. Regional strategy for health promotion for South-East Asia. Regional consultative meeting. Chiang Mai, Thailand, 26 June 2006.
  35. Prevalence of hypertension in Malaysia. Available at http://www.who.int/infobase/reportviewer.aspx?rptcode=all&uncode=458&dm=18&surveycode=102705a1[accessed 2008]
  36. Wilson BJ, Watson MS, Prescott GJ, Sunderland S, Campbell DM, Hannaford P, et al. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. BMJ. 2003;326(7394):845
  37. Zachariah MG, Thankappan KR, Alex SC, Sarma PS, Vasan RS. Prevalence, correlates, awareness, treatment, and control of hypertension in a middle-aged urban population in Kerala. Indian Heart J. 2003;55(3):245–251
  38. Asai Y, Ishikawa S, Kayaba K, Goto T, Nago N, Kario K, et al. [Prevalence, awareness, treatment, and control of hypertension in Japanese rural communities]. Nippon Koshu Eisei Zasshi. 2001;48(10):827–836
  39. Choi KM, Park HS, Han JH, Lee JS, Lee J, Ryu OH, et al. Prevalence of prehypertension and hypertension in a Korean population: Korean national health and nutrition survey 2001. J Hypertens. 2006;24(8):1515–1521
  40. Lim TO, Morad Z. Prevalence, awareness, treatment and control of hypertension in the Malaysian adult population: results from the national health and morbidity survey 1996. Singapore Med J. 2004;45(1):20–27
  41. Howteerakul N, Suwannapong N, Sittilerd R, Rawdaree P. Health risk behaviours, awareness, treatment and control of hypertension among rural community people in Thailand. Asia Pac J Public Health. 2006;18(1):3–9
  42. Antikainen RL, Moltchanov VA, Chukwuma C, Kuulasmaa KA, Marques-Vidal PM, Sans S, et al. Trends in the prevalence, awareness, treatment and control of hypertension: the WHO MONICA project. Eur J Cardiovasc Prev Rehabil. 2006;13(1):13–29
  43. Primatesta P, Poulter NR. Improvement in hypertension management in England: results from the health survey for England 2003. J Hypertens. 2006;24(6):1187–1192
  44. Meisinger C, Heier M, Volzke H, Lowel H, Mitusch R, Hense HW, et al. Regional disparities of hypertension prevalence and management within Germany. J Hypertens. 2006;24(2):293–299
  45. Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ. Selected major risk factors and global and regional burden of disease. Lancet. 2002;360(9343):1347–1360
  46. Toto RD. Treatment of hypertension in chronic kidney disease. Semin Nephrol. 2005;25(6):435–439
  47. Yusuf S, Thom T, Abbott RD. Changes in hypertension treatment and in congestive heart failure mortality in the United States. Hypertension. 1989;13(5 Suppl.):I74–I79
  48. Yu D, Huang J, Hu D, Chen J, Cao J, Li J, et al. Prevalence and risk factors of prehypertension among Chinese adults. J Cardiovasc Pharmacol. 2008;52(4):363–368
  49. Zanchetti A. THE new WHO Expert Committee report on hypertension control. Clin Exp Hypertens. 1996;18(3–4):371–385
  50. Kearney PM, Whelton M, Reynolds K, Whelton PK, He J. Worldwide prevalence of hypertension: a systematic review. J Hypertens. 2004;22(1):11–19
  51. Muntner P, Gu D, Wu X, Duan X, Wenqi G, Whelton PK, et al. Factors associated with hypertension awareness, treatment, and control in a representative sample of the Chinese population. Hypertension. 2004;43(3):578–585
  52. Hu D, Xie J, Fu P, Zhou J, Yu D, Whelton PK, et al. Central rather than overall obesity is related to diabetes in the Chinese population: the InterAsia study. Obesity (Silver Spring). 2007;15(11):2809–2816
  53. National Statistics. Health survey for England 2006, vol. 1. Cardiovascular disease and risk factors in adults.
  54. Prevalence of diabetes in Germany. Available at: http://www.who.int/infobase/reportviewer.aspx?rptcode=all&uncode=276&dm=2&surveycode=102311d128[accessed 2008]
  55. American Diabetes Association . Total prevalence of diabetes & pre-diabetes. Available at http://www.diabetes.org/diabetes-basics/diabetes-statistics/
  56. Gupta R, Sarna M, Thanvi J, Rastogi P, Kaul V, Gupta VP. High prevalence of multiple coronary risk factors in Punjabi Bhatia Community: Jaipur Heart Watch-3. Indian Heart J. 2004;56(6):646–652
  57. Aekplakorn W, Stolk RP, Neal B, Suriyawongpaisal P, Chongsuvivatwong V, Cheepudomwit S, et al. The prevalence and management of diabetes in Thai adults: the international collaborative study of cardiovascular disease in Asia. Diabetes Care. 2003;26(10):2758–2763
  58. Prevalence of diabetes in Malaysia. Available at http://www.who.int/infobase/reportviewer.aspx?rptcode=all&uncode=458&dm=2&surveycode=102705a1[accessed 2008]
  59. King H, Djumaeva S, Abdullaev B, Gacic Dobo M. Epidemiology of glucose intolerance and associated factors in Uzbekistan: a survey in Sirdaria province. Diabetes Res Clin Pract. 2002;55(1):19–27
  60. Iseki K, Oshiro S, Tozawa M, Ikemiya Y, Fukiyama K, Takishita S. Prevalence and correlates of diabetes mellitus in a screened cohort in Okinawa, Japan. Hypertens Res. 2002;25(2):185–190
  61. Gu D, Reynolds K, Duan X, Xin X, Chen J, Wu X, et al. Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: international collaborative study of cardiovascular disease in Asia (InterAsia). Diabetologia. 2003;46(9):1190–1198
  62. Prevalence of diabetes in Republic of Korea. Available at http://www.who.int/infobase/reportviewer.aspx?rptcode=all&uncode=410&dm=2&surveycode=102569a1[accessed 2008]
  63. Helmert USH. Trends in the development and prevalence of obesity in Germany between 1985 and 2002. Gesundheitswesen. 2004;66(7):409–415
  64. Obesity in the US. Fast facts. Available at: http://obesity1.tempdomainname.com/subs/fastfacts/obesity_US.shtml[accessed 2005]
  65. Cheah JS. Obesity in Singapore. Ann Acad Med Singapore. 2001;30(6):561–562
  66. Kantachuvessiri A. Obesity in Thailand. J Med Assoc Thai. 2005;88(4):554–562
  67. Prevalence of obesity in Malaysia. Available at http://www.who.int/infobase/reportviewer.aspx?rptcode=all&uncode=458&dm=5&surveycode=100263a1[accessed 2008]
  68. Prevalence of obesity in India. Available at http://www.who.int/infobase/reportviewer.aspx?rptcode=all&uncode=356&dm=5&surveycode=102703a1[accessed 2008]
  69. Prevalence of obesity in Japan. Available at http://www.who.int/infobase/reportviewer.aspx?rptcode=all&uncode=392&dm=5&surveycode=101431a1[accessed 2008]
  70. Reynolds K, Gu D, Whelton PK, Wu X, Duan X, Mo J, et al. Prevalence and risk factors of overweight and obesity in China. Obesity (Silver Spring). 2007;15(1):10–18
  71. Prevalence of obesity in Republic of Korea. Available at http://www.who.int/infobase/reportviewer.aspx?rptcode=all&uncode=410&dm=5&surveycode=101921a1[accessed 2008]
  72. Morbidity and Mortality Weekly Report . Centers for disease control and prevention, U.S.A. cigarette smoking among adults – United States. <http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5644a2.htm>2006;Available at[accessed 2007]
  73. Prevalence of cigarette smoking in German. Available at http://www.who.int/infobase/reportviewer.aspx?rptcode=all&uncode=276&dm=8&surveycode=102640a1[accessed 2008]
  74. Prevalence of cigarette smoking in India. Available at http://www.who.int/infobase/reportviewer.aspx?rptcode=all&uncode=356&dm=8&surveycode=101711a1[accessed 2008]
  75. Gu D, Kelly TN, Wu X, Chen J, Samet JM, Huang JF, et al. Mortality attributable to smoking in China. N Engl J Med. 2009;360(2):150–159
  76. Inoue M, Hanaoka T, Sasazuki S, Sobue T, Tsugane S. Impact of tobacco smoking on subsequent cancer risk among middle-aged Japanese men and women: data from a large-scale population-based cohort study in Japan – the JPHC study. Prev Med. 2004;38(5):516–522
  77. Jeon HJ, Hahm BJ, Lee HW, Hong JP, Bae JN, Park JI, et al. Prevalence, correlates, and comorbidity of 12-month tobacco dependence among ever-smokers in South Korea, during 1984–2001. J Korean Med Sci. 2008;23(2):207–212
  78. Available at: http://www.who.int/cardiovascular_diseases/en/cvd_atlas_29_world_data_table.pdf.
  79. Available at: <http://www.nationmaster.com/graph/hea_smo_pre_fem_of_adu-health-smoking-prevalence-females-adults>.
  80. WHO . Highlights on health in Uzbekistan. Available at http://www.euro.who.int/document/e71959.pdf1999;
  81. Yang GH, Zhong NS. Effect on health from smoking and use of solid fuel in China. Lancet. 2008;372(9648):1445–1446
  82. Nelson LM. Clinical practice. Primary ovarian insufficiency. N Engl J Med. 2009;360(6):606–614
  83. Kawachi I, Colditz GA, Stampfer MJ, Willett WC, Manson JE, Rosner B, et al. Smoking cessation and time course of decreased risks of coronary heart disease in middle-aged women. Arch Intern Med. 1994;154(2):169–175
  84. Yang G, Kong L, Zhao W, Wan X, Zhai Y, Chen LC, et al. Emergence of chronic non-communicable diseases in China. Lancet. 2008;372(9650):1697–1705
  85. Gritz ER, Thompson B, Emmons K, Ockene JK, Mclerran DF, Nielsen IR. Gender differences among smokers and quitters in the working well trial. Prev Med. 1998;27(4):553–561
  86. Froelicher ES, Christopherson DJ, Miller NH, Martin K. Women's initiative for nonsmoking (WINS) IV: description of 277 women smokers hospitalized with cardiovascular disease. Heart Lung. 2002;31(1):3–14
  87. Nakamura Y, Ueshima H, Okamura T, Kadowaki T, Hayakawa T, Kita Y, et al. A Japanese diet and 19-year mortality: national integrated project for prospective observation of non-communicable diseases and its trends in the aged, 1980. Br J Nutr. 2009;101(11):1696–1705
  88. Zhou BF, Stamler J, Dennis B, Moag-Stahlberg A, Okuda N, Robertson C, et al. Nutrient intakes of middle-aged men and women in China, Japan, United Kingdom, and United States in the late 1990s: the INTERMAP study. J Hum Hypertens. 2003;17(9):623–630
  89. Albert CM, Oh K, Whang W, Manson JE, Chae CU, Stampfer MJ, et al. Dietary alpha-linolenic acid intake and risk of sudden cardiac death and coronary heart disease. Circulation. 2005;112(21):3232–3238
  90. Smith SC, Jackson R, Pearson TA, Fuster V, Yusuf S, Faergeman O, et al. Principles for national and regional guidelines on cardiovascular disease prevention: a scientific statement from the world heart and stroke forum. Circulation. 2004;109(25):3112–3121
  91. Howard BV, Van Horn L, Hsia J, Manson JE, Stefanick ML, Wassertheil-Smoller S, et al. low-fat dietary pattern and risk of cardiovascular disease: the women's health initiative randomized controlled dietary modification trial. JAMA. 2006;295(6):655–666
  92. Gu D, He J, Wu X, Duan X, Whelton PK. Effect of potassium supplementation on blood pressure in Chinese: a randomized, placebo-controlled trial. J Hypertens. 2001;19(7):1325–1331
  93. Lam TH, Ho SY, Hedley AJ, Mak KH, Leung GM. Leisure time physical activity and mortality in Hong Kong: case–control study of all adult deaths in 1998. Ann Epidemiol. 2004;14(6):391–398
  94. Hambrecht R, Walther C, Mobius-Winkler S, Gielen S, Linke A, Conradi K, et al. Percutaneous coronary angioplasty compared with exercise training in patients with stable coronary artery disease: a randomized trial. Circulation. 2004;109(11):1371–1378
  95. Muntner P, Gu D, Wildman RP, Chen J, Qan W, Whelton PK, et al. Prevalence of physical activity among Chinese adults: results from the international collaborative study of cardiovascular disease in Asia. Am J Public Health. 2005;95(9):1631–1636
  96. Henderson SO, Haiman CA, Wilkens LR, Kolonel LN, Wan P, Pike MC. Established risk factors account for most of the racial differences in cardiovascular disease mortality. PLoS One. 2007;2(4):E377
  97. Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, et al. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline. Stroke. 2006;37(6):1583–1633
  98. Li TY, Rana JS, Manson JE, Willett WC, Stampfer MJ, Colditz GA, et al. Obesity as compared with physical activity in predicting risk of coronary heart disease in women. Circulation. 2006;113(4):499–506
  99. Lloyd-Jones DM, Leip EP, Larson MG, D'agostino RB, Beiser A, Wilson PW, et al. Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation. 2006;113(6):791–798
  100. Sauer WH, Berlin JA, Kimmel SE. Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction. Circulation. 2003;108(1):32–36

PII: S0939-4753(10)00065-7

doi: 10.1016/j.numecd.2010.02.016

Nutrition, Metabolism & Cardiovascular Diseases
Volume 20, Issue 6 , Pages 394-404 , July 2010

Article Tools

* Image Usage & Resolution